Abstract:The present work aimed to apply the liquid antisolvent precipitation (LAP) method for preparing the apigenin nanoparticles and thereby improving the solubility and bioavailability of apigenin. The different experimental parameters on particle size were optimized through central composite design (CCD) using the Design-Expert® software. Under the optimum conditions, the particle size of the apigenin nanosuspension was about 159.2 nm. In order to get apigenin nanoparticles, the freeze-drying method was selected and the mannitol was used as a cryoprotectant. Then the solid state properties of the apigenin nanoparticles were investigated using scanning electron microscopy (SEM), differential scanning calorimetry (DSC), thermo gravimetric (TG), and X-ray diffraction (XRD). The results obtained displayed that the apigenin nanoparticles exhibited near-spherical shape and could be transformed into an amorphous form. In addition, the dissolving test, the bioavailability in rats, and the antitumor activity were also studied. The experimental results showed that the solubility of the apigenin nanoparticles were about 29.61 times and 64.81 times of raw apigenin in artificial gastric juice and in artificial intestinal juice, respectively, and the apigenin nanoparticles showed higher dissolution rates compared to raw apigenin, and was about 6.08 times and 6.14 times than that of raw apigenin in artificial gastric juice and in artificial intestinal juice. The oral bioavailability of apigenin nanoparticles was about 4.96 times higher than that of the raw apigenin, but the apigenin nanoparticles had no toxic effect on the organs of rats. In addition, the apigenin nanoparticles had a higher inhibition to HepG2 cells by lower IC50 than that of raw apigenin.

Studies on Pharmacy Characters and Pharmacokinetics of Oral Apigenin Loaded Solid Lipid Nanoparticle

Pharmacokinetics of apigenin solid lipid nanoparticles in rats

Enhanced Solubility and Bioavailability of Apigenin Via Preparation of Solid Dispersions of Mesoporous Silica Nanoparticles.

Preparation of Apigenin Solid Lipid Nanoparticles

Enhanced Bioavailability of Apigenin Via Preparation of a Carbon Nanopowder Solid Dispersion.

Preparation, Characterization and Antitumor Activity Evaluation of Apigenin Nanoparticles by the Liquid Antisolvent Precipitation Technique

Preparation And In Vitro Evaluation Of Apigenin Loaded Lipid Nanocapsules

Preparation of Apigenin Nanocrystals Using Supercritical Antisolvent Process for Dissolution and Bioavailability Enhancement.

Preparation of puerarin solid lipid nanoparticles for oral administration

Casein Nanoparticles As Oral Delivery Carriers for Improved Bioavailability and Hypoglycemic Activity of Apigenin.

Enhanced Oral Bioavailability of Acetylpuerarin by Poly(lactide-Co-glycolide) Nanoparticles Optimized Using Uniform Design Combined with Response Surface Methodology

Preparation and Characterization of Solid Lipid Nanoparticles Loaded with Alpha-Asarone.

Enhancement of Gastrointestinal Absorption of Quercetin by Solid Lipid Nanoparticles.

Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).

Studies on Insulin-Loaded Stearylamine Nanoparticles:Preparation and Physicochemical Properties

Study on Pharmacokinetics of Emodin Solid Lipid Nanoparticles in Rats

Development of A Nanostructured Lipid Carrier-Based Drug Delivery Strategy for Apigenin: Experimental Design Based on CCD-RSM and Evaluation against NSCLC In Vitro

Studies on Drug Release in Vitro and Absorption in Rat in Vivo of Ginsenoside Rd Solid Lipid Nanoparticles

Pharmacokinetics and Tissue Distribution of Apigenin Niosomes

Preparation, Characterization, and in Vitro Release of Chloramphenicol Loaded Solid Lipid Nanoparticles

Preparation and characterization of amoxapine- and naringin-loaded solid lipid nanoparticles: drug-release and molecular-docking studies